삼성서울병원

Ko En

병리과 김석형 교수

진료분야
소화기 병리, 대장암 병리
진료일정 12 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 01 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2001.02 서울대학교 대학원 의학과 박사
1999.02 서울대학교 대학원 의학과 석사
1996.02 서울대학교 의과대학 의학사

경력

경력
2008.03 ~현재 성균관대학교 의과대학 병리학교실 부교수
2008.01 ~현재 미국 세인트루이스 워싱턴 의과대학교 연구원
2001.03 ~현재 병리과 전문의 자격 취득
2007.04 ~ 2007.12 조교수
2003.03 ~ 2007.10 충북대학교 의과대학 전임강사
2001.03 ~ 2003.02 다이노나 ㈜ 책임연구원
1997.03 ~ 2001.02 서울대학교병원 병리과 레지던트
1996.03 ~ 1997.02 아산병원 인턴
  • EXP MOL PATHOL 2020 10.1016/j.yexmp.2020.104560 SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma Piao1, LH; Che, N; Li, HY; Li, MX; Feng, Y; Liu, XZ; Kim, S; Jin, Y; Xuan, YH
    View PubMed
  • J CANCER RES CLIN 2020 10.1007/s00432-020-03437-x Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma Ha1, SY; Yeo, SY; Lee, KW; Kim, SH
    View PubMed
  • NAT GENET 2020 10.1038/s41588-020-0636-z Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer Lee1, HO; Hong, Y; Etlioglu, HE; Cho, YB; Pomelle, V; Van den Bosch, B; Vanhecke, J; Verbandt, S; Hong, H; Min, JW; Kim, N; Eum, HH; Qian, J; Boeckx, B; Lambrechts, D; Tsantoulis, P; De Hertogh, G; Chung, W; Lee, T; An, M; Shin, HT; Joung, JG; Jung, MH; Ko, G; Wirapati, P; Kim, SH; Kim, HC; Yun, SH; Tan, IBH; Ranjan, B; Lee, WY; Kim, TY; Choi, JK; Kim, YJ; Prabhakar, S; Tejpar, S; Park, WY
    View PubMed
  • EXP CELL RES 2020 10.1016/j.yexcr.2020.111861 SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness Piao1, LH; Li, HY; Feng, Y; Yang, ZT; Kim, S; Xuan, YH
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-63996-4 New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts Lee1, E; Yeo, SY; Lee, KW; Lee, JA; Kim, KK; Kim, SH
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed
  • CANCERS 2020 10.3390/cancers12010207 Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase Yun1, SI; Hong, HK; Yeo, SY; Kim, SH; Cho, YB; Kim, KK
    View PubMed
  • MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-0450 Network Inference Analysis Identifies SETDB1 as a Key Regulator for Reverting Colorectal Cancer Cells into Differentiated Normal-Like Cells Lee1, S; Lee, C; Hwang, CY; Kim, D; Han, Y; Hong, SN; Kim, SH; Cho, KH
    View PubMed
  • TUMORI 2019 10.1177/0300891618792476 Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM
    View PubMed
  • J EXP CLIN CANC RES 2019 10.1186/s13046-019-1373-y Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies Kim1, KY; Yoon, M; Cho, Y; Lee, KH; Park, S; Lee, SR; Choi, SY; Lee, D; Yang, C; Cho, EH; Jeon, SD; Kim, SH; Kim, C; Kim, MG
    View PubMed
  • SURGERY 2019 10.1016/j.surg.2018.08.026 Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy Huh1, JW; Kim, HC; Kim, SH; Park, YA; Cho, YB; Yun, SH; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
    View PubMed
  • J GASTROINTEST SURG 2018 10.1007/s11605-018-3815-9 Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer Huh1, JW; Yun, SH; Kim, SH; Park, YA; Cho, YB; Kim, HC; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
    View PubMed
  • PATHOL RES PRACT 2018 10.1016/j.prp.2018.07.016 Expression and prognostic significance of epithelial-mesenchymal transition-related markers and phenotype in serous ovarian cancer Song1, IH; Kim, KR; Lim, S; Kim, SH; Sung, CO
    View PubMed
  • NAT COMMUN 2018 10.1038/s41467-018-05274-6 A positive feedback loop bi-stably activates fibroblasts Yeo1, SY; Lee, KW; Shin, D; An, S; Cho, KH; Kim, SH
    View PubMed
  • CELL DEATH DIS 2018 10.1038/s41419-018-0899-9 DBC1 regulates Wnt/beta-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer Kim1, HJ; Moon, SJ; Kim, SH; Heo, K; Kim, JH
    View PubMed
  • INVEST NEW DRUG 2018 10.1007/s10637-017-0547-8 Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis Lee1, HM; Lee, E; Yeo, SY; Shin, S; Park, HK; Nam, DH; Kim, SH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.315 Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth Lee1, J; Shin, YJ; Lee, K; Cho, HJ; Sa, JK; Lee, SY; Kim, SH; Lee, J; Yoon, Y; Nam, DH
    View PubMed
  • PATHOL RES PRACT 2018 10.1016/j.prp.2018.02.007 Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma Cho1, J; Ha, SY; Kim, SH; Sung, HH; Kwon, GY
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.11.004 Decreased Expression of the Polarity Regulatory PAR Complex Predicts Poor Prognosis of the Patients with Colorectal Adenocarcinoma Yeo1, MK; Kim, JM; Suh, KS; Kim, SH; Lee, OJ; Kim, KH
    View PubMed
  • ANN SURG ONCOL 2018 10.1245/s10434-017-6135-5 Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study Oh1, BY; Park, YA; Huh, JW; Yun, SH; Kim, HC; Chun, HK; Kim, SH; Ha, SY; Lee, WY; Cho, YB
    View PubMed
  • Journal of thoracic disease 2018 10.21037/jtd.2017.12.38 Prognostic significance of histologic classification and tumor disappearance rate by computed tomography in lung cancer Kim1, D; Kim, HK; Kim, SH; Lee, HY; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Shim, YM
    View PubMed
  • BIOCHEM BIOPH RES CO 2017 10.1016/j.bbrc.2017.09.061 Antitumor activity, pharmacokinetics, tumor-homing effect, and hepatotoxicity of a species cross-reactive c-Met antibody Park1, H; Kim, D; Son, E; Shin, S; Sa, JK; Kim, SH; Yoon, Y; Nam, DH
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0187515 Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis Lea1, JC; Lee, HY; Kim, TK; Kim, MS; Park, YM; Kim, J; Park, K; Kweon, MN; Kim, SH; Bae, JW; Hur, KY; Lee, MS
    View PubMed
  • PATHOLOGY 2017 10.1016/j.pathol.2017.05.010 Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer Choi1, JS; Kim, KH; Oh, E; Shin, YK; Seo, J; Kim, SH; Park, S; Choi, YL
    View PubMed
  • INT J MOL SCI 2017 10.3390/ijms18091968 Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain Park1, H; Kim, D; Kim, E; Sa, JK; Lee, HW; Yu, S; Oh, J; Kim, SH; Yoon, Y; Nam, DH
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.17941 Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance Yeo1, SY; Ha, SY; Lee, KW; Cui, Y; Yang, ZT; Xuan, YH; Kim, SH
    View PubMed
  • J Cancer Res Clin Oncol. 2017 Feb;143(2):243-254. doi: 10.1007/s00432-016-2273-6. Epub 2016 Sep 28. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma Yang Z11,2, Cui Y3, Ni W1,2, Kim S4, Xuan Y5,6.
    View PubMed
  • ANZ J Surg. 2016 Dec;86(12):1007-1013. doi: 10.1111/ans.12810. Epub 2014 Aug 12. Prognostic significance of perineural invasion in stage IIA colon cancer Yun JA11, Kim HC1, Kim SH2, Cho YB1, Yun SH1, Lee WY1, Chun HK3.
    View PubMed
  • Oncotarget. 2016 Aug 30;7(35):57066-57076. doi: 10.18632/oncotarget.10974. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells Oh BY11, Kim SY2, Lee YS2, Hong HK2, Kim TW3, Kim SH4, Lee WY1,3, Cho YB1,3,5.
    View PubMed
  • Oncotarget. 2016 Aug 2;7(31):49334-49348. doi: 10.18632/oncotarget.10340. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma Son SW11, Kim SH2,3, Moon EY4, Kim DH5, Pyo S6, Um SH1,3.
    View PubMed
  • Autophagy. 2016 Aug 2;12(8):1390-403. doi: 10.1080/15548627.2016.1184799. Epub 2016 Jun 23. Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis Lee HY11, Kim J2,3, Quan W1, Lee JC1, Kim MS4, Kim SH5, Bae JW4, Hur KY1, Lee MS2.
    View PubMed
  • Oncogene. 2016 Jun 30;35(26):3410-8. doi: 10.1038/onc.2015.401. Epub 2015 Oct 19. Positive regulation of beta-catenin-PROX1 signaling axis by DBC1 in colon cancer progression Yu EJ11,2, Kim SH1,3, Kim HJ1,2, Heo K4, Ou CY5, Stallcup MR5, Kim JH1,2.
    View PubMed
  • Oncotarget. 2016 Apr 12;7(15):19610-9. doi: 10.18632/oncotarget.7526. Molecular characterization of colorectal cancer patients and concomitant patient-derived tumor cell establishment Song HN11,2, Lee C3,4, Kim ST1, Kim SY1, Kim NK3, Jang J1, Kang M1, Jang H1, Ahn S5, Kim SH5, Park Y6, Cho YB6, Heo JW6, Lee WY6, Park JO1, Lim HY1, Kang WK1, Park YS1, Park WY3,7,4, Lee J1, Kim HC6.
    View PubMed
  • Malays J Pathol. 2016 Apr;38(1):49-54. Heterotopic ossification in appendiceal mucinous neoplasms: clinicopathological characteristics of 3 cases Choi SY11, Park S, Kim KH, Kim SH.
    View PubMed
  • BMC Cancer. 2016 Feb 18;16:120. doi: 10.1186/s12885-016-2141-4. The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis Kim HS11,2, Heo JS3, Lee J4, Lee JY5, Lee MY6, Lim SH7, Lee WY8, Kim SH9, Park YA10, Cho YB11, Yun SH12, Kim ST13, Park JO14, Lim HY15, Choi YS16, Kwon WI17, Kim HC18, Park YS19.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2582. doi: 10.1097/MD.0000000000002582. Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation Huh JW11, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Park HC, Choi DH, Park JO, Park YS, Chun HK.
    View PubMed
  • Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
    View PubMed
  • PLoS One. 2016 Jan 5;11(1):e0145807. doi: 10.1371/journal.pone.0145807. eCollection 2016. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma Yang ZT11,2, Yeo SY3,4, Yin YX1,5, Lin ZH1,2, Lee HM3,4, Xuan YH1,2, Cui Y6, Kim SH3,4.
    View PubMed
  • Dis Colon Rectum. 2015 Nov;58(11):1041-7. doi: 10.1097/DCR.0000000000000456. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer Oh BY11, Yun HR, Kim SH, Yun SH, Kim HC, Lee WY, Chun HK, Cho YB.
    View PubMed
  • Oncotarget. 2015 Nov 17;6(36):39028-35. doi: 10.18632/oncotarget.5494. NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line Lee SJ11, Li GG2, Kim ST1, Hong ME3, Jang J1, Yoon N3, Ahn SM3, Murphy D2, Christiansen J2, Wei G2, Hornby Z2, Lee DW4, Park JO1,5, Park YS1, Lim HY1, Hong SN6, Kim SH3, Kang WK1, Park K1, Park WY7, Kim KM3,5, Lee J1.
    View PubMed
  • Oncotarget. 2015 Nov 24;6(37):40360-9. doi: 10.18632/oncotarget.5465. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients Kim ST11, Lee WS2, Lanman RB3, Mortimer S3, Zill OA3, Kim KM4,5, Jang KT5, Kim SH5, Park SH1, Park JO1,4, Park YS1, Lim HY1, Eltoukhy H3, Kang WK1, Lee WY6, Kim HC6, Park K1,4, Lee J1,4, Talasaz A3.
    View PubMed
  • BMC Cancer. 2015 Oct 20;15:747. doi: 10.1186/s12885-015-1759-y. Exploratory biomarker analysis for treatment response in KRAS wild type metastatic colorectal cancer patients who received cetuximab plus irinotecan Kim ST1, Ahn TJ, Lee E, Do IG, Lee SJ, Park SH, Park JO, Park YS, Lim HY, Kang WK, Kim SH, Lee J, Kim HC
    View PubMed
  • Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13081-6. doi: 10.1073/pnas.1407075112. Epub 2015 Oct 5. Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice Lee EK11, Joo EH1, Song KA1, Choi B2, Kim M2, Kim SH3, Kim SJ4, Kang MS5.
    View PubMed
  • Oncotarget. 2015 Sep 15;6(27):24320-32. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening Lee J11, Kim HC2, Hong JY3, Wang K4, Kim SY1, Jang J1, Kim ST1, Park JO1, Lim HY1, Kang WK1, Park YS1, Lee J1, Lee WY2, Park YA2, Huh JW2, Yun SH2, Do IG5, Kim SH5, Balasubramanian S4, Stephens PJ4, Ross JS4,6, Li GG7, Hornby Z7, Ali SM4, Miller VA4, Kim KM5,8, Ou SH9.
    View PubMed
  • Oncogene. 2015 Aug 20;34(34):4500-8. doi: 10.1038/onc.2014.381. Epub 2014 Nov 24. A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer Kim HJ11,2, Kim SH1,3, Yu EJ1,2, Seo WY1,2, Kim JH1,2.
    View PubMed
  • Anticancer Res. 2015 Jul;35(7):3925-31. Altered Expression of Yes-associated Protein and beta-Catenin in Non-neoplastic and Neoplastic Gastric Surface Epithelia Kim SH11, Lee OJ2, Kwon JL3, Kim JM4, Sul HJ5, Song KS3, Kim KH6.
    View PubMed
  • Int J Cancer. 2015 May 15;136(10):2284-92. doi: 10.1002/ijc.29286. Epub 2014 Nov 6. GAGE12 mediates human gastric carcinoma growth and metastasis Lee EK11, Song KA, Chae JH, Kim KM, Kim SH, Kang MS.
    View PubMed
  • Yonsei Med J. 2015 Jan;56(1):82-8. doi: 10.3349/ymj.2015.56.1.82. Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis Huh JW11, Lee WY2, Kim SH3, Park YA1, Cho YB1, Yun SH1, Kim HC1, Park HC4, Choi DH4, Park JO5, Park YS5, Chun HK6.
    View PubMed
  • Cancer Res. 2015 Jan 1;75(1):73-85. doi: 10.1158/0008-5472.CAN-14-0350. Epub 2014 Nov 3. Twist1 Is a Key Regulator of Cancer-Associated Fibroblasts Lee KW11, Yeo SY1, Sung CO2, Kim SH3.
    View PubMed
  • Oncotarget. 2014 Dec 15;5(23):12260-72. ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma Yeo SY11, Ha SY2, Yu EJ1, Lee KW1, Kim JH3, Kim SH4.
    View PubMed
  • Med Oncol. 2014 Nov;31(11):236. doi: 10.1007/s12032-014-0236-9. Epub 2014 Sep 30. The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma Cho SY11, Ha SY, Huang SM, Kim JH, Kang MS, Yoo HY, Kim HH, Park CK, Um SH, Kim KH, Kim SH.
    View PubMed
  • Ann Surg Treat Res. 2014 Sep;87(3):123-30. doi: 10.4174/astr.2014.87.3.123. Epub 2014 Aug 26. hMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines Kim SJ11, Kim HR1, Kim SH2, Han JH3, Cho YB1, Yun SH1, Lee WY1, Kim HC1.
    View PubMed
  • Cancer Genomics Proteomics. 2014 Sep-Oct;11(5):259-66. Transcriptome Analysis of CD133-positive Stem Cells and Prognostic Value of Survivin in Colorectal Cancer Kim ST11, Sohn I2, DO IG3, Jang J4, Kim SH3, Jung IH5, Park JO1, Park YS1, Talasaz A6, Lee J1, Kim HC7.
    View PubMed
  • Colorectal Dis. 2014 Aug;16(8):O257-63. doi: 10.1111/codi.12554. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer Kim TG11, Park W, Choi DH, Kim SH, Kim HC, Lee WY, Park JO, Park YS.
    View PubMed
  • PLoS One. 2014 Aug 4;9(8):e103551. doi: 10.1371/journal.pone.0103551. eCollection 2014. Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status Lee J11, Jain A2, Kim P2, Lee T2, Kuller A2, Princen F2, In-GuDo3, Kim SH3, Park JO1, Park YS1, Singh S2, Kim HC4.
    View PubMed
  • Oncology. 2014;86(5-6):318-28. doi: 10.1159/000360794. Epub 2014 Jun 7. Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer Yun JA11, Kim SH, Hong HK, Yun SH, Kim HC, Chun HK, Cho YB, Lee WY.
    View PubMed
  • J Clin Pathol. 2014 Jul;67(7):576-81. doi: 10.1136/jclinpath-2013-202163. Epub 2014 Apr 2. Overexpression of integrin alpha v correlates with poor prognosis in colorectal cancer Ha SY11, Shin J2, Kim JH3, Kang MS3, Yoo HY3, Kim HH3, Um SH4, Kim SH5.
    View PubMed
  • Dig Dis Sci. 2014 Jun;59(6):1244-54. doi: 10.1007/s10620-013-2994-1. Epub 2013 Dec 25. Chronic Tamoxifen Use Is Associated with a Decreased Risk of Intestinal Metaplasia in Human Gastric Epithelium Moon CM11, Kim SH, Lee SK, Hyeon J, Koo JS, Lee S, Wang JS, Huh WJ, Khurana SS, Mills JC.
    View PubMed
  • PLoS One. 2014 Jun 19;9(6):e99955. doi: 10.1371/journal.pone.0099955. eCollection 2014. The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma Ha SY11, Yeo SY2, Xuan YH3, Kim SH4.
    View PubMed
  • Invest New Drugs. 2014 Jun;32(3):535-41. doi: 10.1007/s10637-014-0065-x. Epub 2014 Jan 28. Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab Lee J11, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, Cho YB, Lee WY, Yun SH, Kim HC, Park YS, Kang WK.
    View PubMed
  • J Surg Oncol. 2014 Jun;109(8):848-52. doi: 10.1002/jso.23592. Epub 2014 Mar 13. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: Predictive role of lymph node metastasis and survival Huh JW11, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Chun HK.
    View PubMed
  • Oncology. 2014;86(3):159-69. doi: 10.1159/000358064. Epub 2014 Mar 12. Low Expression of Transforming Growth Factor Beta-1 in Cancer Tissue Predicts a Poor Prognosis for Patients with Stage III Rectal Cancers Chun HK11, Jung KU, Choi YL, Hong HK, Kim SH, Yun SH, Kim HC, Lee WY, Cho YB.
    View PubMed
  • Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
    View PubMed
  • Cancer Lett. 2014 Feb 1;343(1):62-73. doi: 10.1016/j.canlet.2013.09.013. Epub 2013 Sep 16. Twist1 is essential in maintaining mesenchymal state and tumor-initiating properties in synovial sarcoma Lee KW11, Lee NK2, Ham S3, Roh TY4, Kim SH5.
    View PubMed
  • Virchows Arch. 2014 Jan;464(1):19-27. doi: 10.1007/s00428-013-1504-3. Epub 2013 Nov 19. Overexpression of matriptase correlates with poor prognosis in esophageal squamous cell carcinoma Ha SY11, Kim KY, Lee NK, Kim MG, Kim SH.
    View PubMed
  • Oncotarget. 2014 Jan 30;5(2):519-29. Collagen Triple Helix Repeat Containing 1 (CTHRC1) acts via ERK-dependent induction of MMP9 to promote invasion of colorectal cancer cells Kim HC11, Kim YS, Oh HW, Kim K, Oh SS, Kim JT, Kim BY, Lee SJ, Choe YK, Kim DH, Kim SH, Chae SW, Kim KD, Lee HG.
    View PubMed
  • Int J Cancer. 2015 Jan 15;136(2):310-21. doi: 10.1002/ijc.29006. Epub 2014 Jun 26. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo Lee KW11, Sung CO, Kim JH, Kang M, Yoo HY, Kim HH, Um SH, Kim SH.
    View PubMed
  • Histol Histopathol. 2013 Nov;28(11):1483-90. Epub 2013 May 15. Differential expression of Yes-associated protein and phosphorylated Yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma Kim DH11, Kim SH, Lee OJ, Huang SM, Kwon JL, Kim JM, Kim JY, Seong IO, Song KS, Kim KH.
    View PubMed
  • Oncogene. 2013 Aug 29;32(35):4160-8. doi: 10.1038/onc.2012.420. Epub 2012 Sep 17. SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis Yu EJ11, Kim SH, Kim MJ, Seo WY, Song KA, Kang MS, Yang CK, Stallcup MR, Kim JH.
    View PubMed
  • J Clin Pathol. 2013 Jul;66(7):601-6. doi: 10.1136/jclinpath-2012-201271. Epub 2013 Mar 26. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition Sung CO11, Choi H, Lee KW, Kim SH.
    View PubMed
  • Dig Dis Sci. 2013 Apr;58(4):989-97. doi: 10.1007/s10620-012-2470-3. Epub 2012 Nov 18. Smad3 and Smad3 Phosphoisoforms Are Prognostic Markers of Gastric Carcinoma Kim SH11, Kim KH, Ahn S, Hyeon J, Park CK.
    View PubMed
  • Mod Pathol. 2013 Mar;26(3):327-35. doi: 10.1038/modpathol.2012.161. Epub 2012 Sep 21. Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma Kim SH11, Jang YH, Chau GC, Pyo S, Um SH.
    View PubMed
  • Hum Pathol. 2013 Feb;44(2):226-36. doi: 10.1016/j.humpath.2012.05.011. Epub 2012 Aug 31. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma Kim SH11, Chau GC, Jang YH, Lee SI, Pyo S, Um SH.
    View PubMed
  • Anticancer Res. 2012 Sep;32(9):3835-40. Correlation of Expression of Phosphorylated and Non-phosphorylated Yes-associated Protein with Clinicopathological Parameters in Esophageal Squamous Cell Carcinoma in a Korean Population Yeo MK11, Kim SH, Kim JM, Huang SM, Kim MR, Song KS, Kim KH.
    View PubMed
  • Pathol Res Pract. 2012 Aug 15;208(8):462-9. doi: 10.1016/j.prp.2012.05.012. Epub 2012 Jul 4. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma Ha SY11, Kim SH.
    View PubMed
  • Biochem Biophys Res Commun. 2012 Jul 6;423(3):454-60. doi: 10.1016/j.bbrc.2012.05.140. Epub 2012 Jun 2. Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer Lee KW11, Lee NK, Kim JH, Kang MS, Yoo HY, Kim HH, Um SH, Kim SH.
    View PubMed
  • Histol Histopathol. 2012 May;27(5):581-91. Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung Kim SH11, Kim JM, Shin MH, Kim CW, Huang SM, Kang DW, Suh KS, Yi ES, Kim KH.
    View PubMed
  • Int J Cancer. 2012 Apr 15;130(8):1925-36. doi: 10.1002/ijc.26197. Epub 2011 Aug 8. The synergistic therapeutic effect of cisplatin with Human Papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo Jung HS11, Erkin OC, Kwon MJ, Kim SH, Jung JI, Oh YK, Her SW, Ju W, Choi YL, Song SY, Kim JK, Kim YD, Shim GY, Shin YK.
    View PubMed
  • Indian J Exp Biol. 2012 Mar;50(3):195-200. Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats Yoon WS11, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.
    View PubMed
  • Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):51-9. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy Kim SH11, Ahn S, Park CK.
    View PubMed
  • Ann Surg Oncol. 2012 Jan;19(1):326-35. doi: 10.1245/s10434-011-1867-0. Epub 2011 Jul 6. Twist1 Is an Independent Prognostic Factor of Esophageal Squamous Cell Carcinoma and Associated with Its Epithelial-Mesenchymal Transition Lee KW11, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH.
    View PubMed
  • Histol Histopathol. 2012 Jan;27(1):49-58. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis Kim SH11, Kim JH, Yu EJ, Lee KW, Park CK.
    View PubMed
  • Lab Invest. 2011 Nov;91(11):1652-67. doi: 10.1038/labinvest.2011.117. Epub 2011 Aug 15. Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma Kwon MJ11, Kim SH, Jeong HM, Jung HS, Kim SS, Lee JE, Gye MC, Erkin OC, Koh SS, Choi YL, Park CK, Shin YK.
    View PubMed
  • Am J Pathol. 2011 Oct;179(4):1827-38. doi: 10.1016/j.ajpath.2011.06.032. Epub 2011 Aug 18. Twist1 Is Up-Regulated in Gastric Cancer-Associated Fibroblasts with Poor Clinical Outcomes Sung CO11, Lee KW, Han S, Kim SH.
    View PubMed
  • Nucleic Acids Res. 2011 Sep 1;39(16):6932-43. doi: 10.1093/nar/gkr347. Epub 2011 May 19. Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor alpha activity and co-activator synergy Yu EJ11, Kim SH, Heo K, Ou CY, Stallcup MR, Kim JH.
    View PubMed
  • Mod Pathol. 2011 Aug;24(8):1060-8. doi: 10.1038/modpathol.2011.59. Epub 2011 May 6. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis Sung CO11, Park CK, Kim SH.
    View PubMed
  • J Cancer Res Clin Oncol. 2011 Jan;137(1):49-54. doi: 10.1007/s00432-010-0858-z. Epub 2010 Mar 9. Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder Xuan Y11, Kim S, Lin Z.
    View PubMed
  • Ann Surg Oncol. 2011 Jan;18(1):273-81. doi: 10.1245/s10434-010-1289-4. Epub 2010 Sep 14. Low Expression of Claudin-4 is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma Sung CO11, Han SY, Kim SH.
    View PubMed
  • Am J Pathol. 2010 Sep;177(3):1514-33. doi: 10.2353/ajpath.2010.100328. Epub 2010 Aug 13. The Transcription Factor MIST1 Is a Novel Human Gastric Chief Cell Marker Whose Expression Is Lost in Metaplasia, Dysplasia, and Carcinoma Lennerz JK11, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK, Mills JC.
    View PubMed
  • J Korean Med Sci. 2009 Jun;24(3):384-91. doi: 10.3346/jkms.2009.24.3.384. Epub 2009 Jun 12. Ca2+-activated K+ Current in Freshly Isolated c-Kit Positive Cells in Guinea-pig Stomach Kim YC11, Suzuki H, Xu WX, Choi W, Kim SH, Lee SJ.
    View PubMed
  • Pathol Int. 2009 May;59(5):279-87. doi: 10.1111/j.1440-1827.2009.02366.x. Expression of Sonic hedgehog signaling molecules in normal, hyperplastic and carcinomatous endometrium Kim KH11, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Chung YS, Kim SH.
    View PubMed
  • Histol Histopathol. 2009 Mar;24(3):309-16. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium Kim KH11, Choi JS, Kim JM, Choi YL, Shin YK, Lee HC, Seong IO, Kim BK, Chae SW, Kim SH.
    View PubMed
  • Histol Histopathol. 2008 Dec;23(12):1439-52. Extensive alteration in the expression profiles of TGFB pathway signaling components and TP53 is observed along the gastric dysplasia-carcinoma sequence Kim SH11, Lee SH, Choi YL, Wang LH, Park CK, Shin YK.
    View PubMed
  • The expression of G1-S cell cycle inhibitors in normal placenta and gestational trophoblastic diseases